Access the full text.
Sign up today, get DeepDyve free for 14 days.
Bei Zhang, J. Berger, Et-ding Hu, D. Szalkowski, Sylvia White-Carrington, B. Spiegelman, D. Moller (1996)
Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.Molecular endocrinology, 10 11
D. Fegley, S. Gaetani, A. Duranti, A. Tontini, M. Mor, G. Tarzia, D. Piomelli (2005)
Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide DeactivationJournal of Pharmacology and Experimental Therapeutics, 313
M. Caterina, M. Schumacher, M. Tominaga, Tobias Rosen, J. Levine, D. Julius (1997)
The capsaicin receptor: a heat-activated ion channel in the pain pathwayNature, 389
J. Parrish, D. Nichols (2006)
Serotonin 5‐HT2A receptor activation induces 2‐arachidonoylglycerol release through a phospholipase c‐dependent mechanismJournal of Neurochemistry, 99
Stephen Alexander, D. Kendall, S. Hill (1989)
Differences in the adenosine receptors modulating inositol phosphates and cyclic AMP accumulation in mammalian cerebral cortexBritish Journal of Pharmacology, 98
R. Pertwee (1997)
Pharmacology of cannabinoid CB1 and CB2 receptors.Pharmacology & therapeutics, 74 2
G. Zaman (2005)
Screening for Modulators of G Protein-Coupled Receptors.Combinatorial chemistry & high throughput screening, 8 4
Sugiura Sugiura, Kodaka Kodaka, Nakane Nakane, Miyashita Miyashita, Kondo Kondo, Suhara Suhara (1999)
Evidence that the cannabinoid CB1 receptor is a 2‐arachidonoylglycerol receptor. Structure‐activity relationship of 2‐arachidonoylglycerol ether‐linked analogues, and related compoundsJ Biol Chem, 274
E. Graham, N. Ball, Emma Scotter, P. Narayan, M. Dragunow, M. Glass, Fromthe DepartmentofPharmacologyandthe (2006)
Induction of Krox-24 by Endogenous Cannabinoid Type 1 Receptors in Neuro2A Cells Is Mediated by the MEK-ERK MAPK Pathway and Is Suppressed by the Phosphatidylinositol 3-Kinase Pathway*Journal of Biological Chemistry, 281
A. Hampson, L. Bornheim, M. Scanziani, C. Yost, A. Gray, Bonnie Hansen, D. Leonoudakis, P. Bickler (1998)
Dual Effects of Anandamide on NMDA Receptor‐Mediated Responses and NeurotransmissionJournal of Neurochemistry, 70
I. Bojesen, H. Hansen (2006)
Effect of an unstirred layer on the membrane permeability of anandamide Published, JLR Papers in Press, December 19, 2005.Journal of Lipid Research, 47
J. Moody, K. Kozak, C. Ji, L. Marnett (2001)
Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase.Biochemistry, 40 4
C. Yost, A. Hampson, D. Leonoudakis, D. Koblin, L. Bornheim, A. Gray (1998)
Oleamide Potentiates Benzodiazepine-Sensitive gamma-Aminobutyric Acid Receptor Activity but Does Not Alter Minimum Alveolar Anesthetic ConcentrationAnesthesia & Analgesia, 86
R. Mistry, Nicki Golding, R. Challiss (1998)
Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I‐ and II‐ selective metabotropic glutamate receptor agonistsBritish Journal of Pharmacology, 123
K. Burns, J. Heuvel (2007)
Modulation of PPAR activity via phosphorylation.Biochimica et biophysica acta, 1771 8
S. Vandevoorde, C. Fowler (2005)
Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrateBritish Journal of Pharmacology, 145
M. Bouaboula, C. Poinot-Chazel, B. Bourrie, X. Canat, B. Calandra, M. Rinaldi-Carmona, G. Fur, P. Casellas (1995)
Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.The Biochemical journal, 312 ( Pt 2)
D. Smart, M. Gunthorpe, J. Jerman, S. Nasir, J. Gray, A. Muir, J. Chambers, A. Randall, J. Davis (2000)
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)British Journal of Pharmacology, 129
K. Mackie, B. Hille (1992)
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.Proceedings of the National Academy of Sciences of the United States of America, 89
M. Barann, G. Molderings, M. Brüss, H. Bönisch, B. Urban, M. Göthert (2002)
Direct inhibition by cannabinoids of human 5‐HT3A receptors: probable involvement of an allosteric modulatory siteBritish Journal of Pharmacology, 137
Pestonjamasp Pestonjamasp, Burstein Burstein (1998)
Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune systemBiochim Biophys Acta—Lip Lip Met, 1394
G. Rossi, V. Gasperi, R. Paro, D. Barsacchi, S. Cecconi, M. Maccarrone (2007)
Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells.Endocrinology, 148 3
M. Yu, D. Ives, C. Ramesha (1997)
Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2*The Journal of Biological Chemistry, 272
Toshiyuki Kimura, Tomoko Ohta, Kazuhito Watanabe, Hidetoshi Yoshimura, I. Yamamoto (1998)
Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor.Biological & pharmaceutical bulletin, 21 3
J. Gong, E. Onaivi, H. Ishiguro, Qing-Rong Liu, P. Tagliaferro, A. Brusco, G. Uhl (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brainBrain Research, 1071
R. Schild, C. Sonnenberg-Hirche, W. Schaiff, İ. Bildirici, D. Nelson, Y. Sadovsky (2006)
The kinase p38 Regulates Peroxisome Proliferator Activated Receptor-γ in Human TrophoblastsPlacenta, 27
N. Hájos, I. Katona, S. Naiem, K. Mackie, C. Ledent, I. Módy, T. Freund (2000)
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillationsEuropean Journal of Neuroscience, 12
Tsuboi Tsuboi, Zhao Zhao, Okamoto Okamoto, Araki Araki, Ueno Ueno, Sakamoto Sakamoto (2007)
Predominant expression of lysosomal N‐acylethanolamine‐hydrolyzing acid amidase in macrophages revealed by immunochemical studiesBiochim Biophys Acta—Mol Cell Biol Lip, 1771
C. Spivak, C. Lupica, M. Oz (2007)
The Endocannabinoid Anandamide Inhibits the Function of α4β2 Nicotinic Acetylcholine ReceptorsMolecular Pharmacology, 72
N. Ghafouri, G. Tiger, R. Razdan, A. Mahadevan, R. Pertwee, B. Martin, C. Fowler (2004)
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2‐arachidonoylglycerolBritish Journal of Pharmacology, 143
K. Mackie, Y. Lai, R. Westenbroek, R. Mitchell (1995)
Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor, 15
K. Mackie, W. Devane, B. Hille (1993)
Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.Molecular pharmacology, 44 3
J. Alexander, B. Cravatt (2006)
The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases.Journal of the American Chemical Society, 128 30
Ho By, Y. Uezono, S. Takada, I. Takase, F. Izumi (1999)
Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels.Receptors & channels, 6 5
T. Sugiura, K. Waku (2002)
Cannabinoid receptors and their endogenous ligands.Journal of biochemistry, 132 1
N. Sang, Jian Zhang, Chu Chen (2007)
COX‐2 oxidative metabolite of endocannabinoid 2‐AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicityJournal of Neurochemistry, 102
C. Fowler, U. Janson, R. Johnson, G. Wahlström, A. Stenström, K. Norström, G. Tiger (1999)
Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen.Archives of biochemistry and biophysics, 362 2
Maria Cascio, Alberto Minassi, A. Ligresti, G. Appendino, S. Burstein, V. Marzo (2004)
A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase.Biochemical and biophysical research communications, 314 1
Y. Do, R. Mckallip, M. Nagarkatti, P. Nagarkatti (2004)
Activation through Cannabinoid Receptors 1 and 2 on Dendritic Cells Triggers NF-κB-Dependent Apoptosis: Novel Role for Endogenous and Exogenous Cannabinoids in Immunoregulation1The Journal of Immunology, 173
L. Khachigian (2006)
Early growth response-1 in cardiovascular pathobiology.Circulation research, 98 2
M. McFarland, E. Barker (2004)
Anandamide transport.Pharmacology & therapeutics, 104 2
W. Niforatos, Xufeng Zhang, M. Lake, K. Walter, T. Neelands, T. Holzman, V. Scott, C. Faltynek, R. Moreland, Jun Chen (2007)
Activation of TRPA1 Channels by the Fatty Acid Amide Hydrolase Inhibitor 3′-Carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597)Molecular Pharmacology, 71
D. Demuth, A. Molleman (2006)
Cannabinoid signalling (review)Life Sciences
L. Petrocellis, Constance Chu, A. Moriello, Juliane Kellner, J. Walker, V. Marzo (2004)
Actions of two naturally occurring saturated N‐acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channelsBritish Journal of Pharmacology, 143
V. Vellani, S. Mapplebeck, A. Moriondo, John Davis, P. McNaughton (2001)
Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamideThe Journal of Physiology, 534
Theodore Price, A. Patwardhan, C. Flores, K. Hargreaves (2005)
A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neuronsNeuropharmacology, 49
S. Moore, G. Nomikos, A. Dickason-Chesterfield, D. Schober, J. Schaus, B. Ying, Y.C. Xu, L. Phebus, R. Simmons, D. Li, S. Iyengar, C. Felder (2005)
Identification of a high-affinity binding site involved in the transport of endocannabinoids.Proceedings of the National Academy of Sciences of the United States of America, 102 49
T. Bisogno, N. Sepe, L. Petrocellis, R. Mechoulam, V. Marzo (1997)
The sleep inducing factor oleamide is produced by mouse neuroblastoma cells.Biochemical and biophysical research communications, 239 2
M. Bouaboula, C. Poinot-Chazel, Jean Marchand, X. Canat, B. Bourrié, M. Rinaldi-Carmona, B. Calandra, G. Fur, P. Casellas (1996)
Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.European journal of biochemistry, 237 3
R. Evans, R. Scott, R. Ross (2004)
Multiple actions of anandamide on neonatal rat cultured sensory neuronesBritish Journal of Pharmacology, 141
A. Chaytor, P. Martin, W. Evans, M. Randall, T. Griffith (1999)
The endothelial component of cannabinoid‐induced relaxation in rabbit mesenteric artery depends on gap junctional communicationThe Journal of Physiology, 520
R. Hampson, G. Evans, J. Mu, S. Zhuang, V. King, S. Childers, S. Deadwyler (1995)
Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium "A-current" in cultured rat hippocampal neurons.Life sciences, 56 23-24
Liao Liao, Zheng Zheng, David David, Nicholson Nicholson (2004)
Inhibition of voltage‐sensitive sodium channels by the cannabinoid 1 receptor antagonist AM 251 in mammalian brainPharmacol Toxicol, 94
N. Gavva, A. Bannon, S. Surapaneni, D. Hovland, S. Lehto, A. Gore, T. Juan, H. Deng, Bora Han, L. Klionsky, Rongzhen Kuang, A. Le, R. Tamir, Jue Wang, B. Youngblood, D. Zhu, M. Norman, E. Magal, J. Treanor, J. Louis (2007)
The Vanilloid Receptor TRPV1 Is Tonically Activated In Vivo and Involved in Body Temperature RegulationThe Journal of Neuroscience, 27
A. Tóth, J. Boczán, N. Kedei, E. Lizanecz, Z. Bagi, Z. Papp, I. Edes, L. Csiba, P. Blumberg (2005)
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain.Brain research. Molecular brain research, 135 1-2
Saori Oka, Shin Yanagimoto, S. Ikeda, Maiko Gokoh, S. Kishimoto, K. Waku, Y. Ishima, T. Sugiura (2005)
Evidence for the Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in 12-O-Tetradecanoylphorbol-13-acetate-induced Acute Inflammation in Mouse Ear*Journal of Biological Chemistry, 280
I. Katona, E. Rancz, L. Acsády, C. Ledent, K. Mackie, N. Hájos, T. Freund (2001)
Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic TransmissionThe Journal of Neuroscience, 21
S. Burstein, Jeffrey Adams, H. Bradshaw, Cristian Fraioli, Ronald, G. Rossetti, R. Salmonsen, J. Shaw, J. Walker, E. Robert, Zipkin, R. Zurier (2007)
Potential anti-inflammatory actions of the elmiric (lipoamino) acids.Bioorganic & medicinal chemistry, 15 10
C. Vásquez, R. Navarro-Polanco, M. Huerta, X. Trujillo, F. Andrade, B. Trujillo-Hernández, Leonardo Hernández-Hernández (2003)
Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells.Canadian journal of physiology and pharmacology, 81 5
T. Pulgar, G. Velasco, Manuel Guzmán (2000)
The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.The Biochemical journal, 347 Pt 2
L. Thors, C. Fowler (2006)
Is there a temperature‐dependent uptake of anandamide into cells?British Journal of Pharmacology, 149
H. Overton, A. Babbs, S. Doel, M. Fyfe, Lisa Gardner, Graeme Griffin, H. Jackson, M. Procter, C. Rasamison, Mads Tang-Christensen, P. Widdowson, G. Williams, C. Reynet (2006)
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents.Cell metabolism, 3 3
Jianchun Chen, Jian-Kang Chen, J. Falck, S. Anjaiah, J. Capdevila, Raymond Harris (2007)
Mitogenic Activity and Signaling Mechanism of 2-(14,15- Epoxyeicosatrienoyl)Glycerol, a Novel Cytochrome P450 Arachidonate MetaboliteMolecular and Cellular Biology, 27
V. Marzo, S. Petrosino (2007)
Endocannabinoids and the regulation of their levels in health and diseaseCurrent Opinion in Lipidology, 18
S. Bura, A. Castañé, C. Ledent, O. Valverde, R. Maldonado (2007)
Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processesBritish Journal of Pharmacology, 150
W. Niforatos, Xufeng Zhang, M. Lake, K. Walter, T. Neelands, T. Holzman, V. Scott, C. Faltynek, R. Moreland, Jun Chen (2007)
Activation of TRPA 1 Channels by the Fatty Acid Amide Hydrolase Inhibitor 3-Carbamoylbiphenyl-3-yl cyclohexylcarbamate ( URB 597 )
K. Jonsson, S. Vandevoorde, D. Lambert, G. Tiger, C. Fowler (2001)
Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamideBritish Journal of Pharmacology, 133
L. Petrocellis, T. Bisogno, M. Maccarrone, John Davis, A. Finazzi-Agrò, V. Marzo (2001)
The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism*The Journal of Biological Chemistry, 276
M. Maccarrone, M. Defelici, F. Klinger, N. Battista, F. Fezza, E. Dainese, G. Siracusa, A. Finazzi-Agrò (2004)
Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus.Molecular human reproduction, 10 4
A. Lichtman, D. Leung, C. Shelton, A. Saghatelian, C. Hardouin, D. Boger, B. Cravatt (2004)
Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and SelectivityJournal of Pharmacology and Experimental Therapeutics, 311
D. Boger, J. Patterson, Qing Jin (1998)
Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide.Proceedings of the National Academy of Sciences of the United States of America, 95 8
Yan Sun, Stephen Alexander, D. Kendall, A. Bennett (2006)
Cannabinoids and PPARα signallingBiochemical Society Transactions, 34
K. Starowicz, S. Nigam, V. Marzo (2007)
Biochemistry and pharmacology of endovanilloids.Pharmacology & therapeutics, 114 1
László Offertáler, F. Mo, S. Batkai, Jie Liu, M. Begg, R. Razdan, B. Martin, R. Bukoski, G. Kunos (2003)
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.Molecular pharmacology, 63 3
C. Fowler, S. Holt, G. Tiger (2003)
Acidic Nonsteroidal Anti-inflammatory Drugs Inhibit Rat Brain Fatty Acid Amide Hydrolase in a pH-dependent MannerJournal of Enzyme Inhibition and Medicinal Chemistry, 18
C. Moore, S. Milano, J. Benovic (2007)
Regulation of receptor trafficking by GRKs and arrestins.Annual review of physiology, 69
P. Millns, V. Chapman, D. Kendall (2001)
Cannabinoid inhibition of the capsaicin‐induced calcium response in rat dorsal root ganglion neuronesBritish Journal of Pharmacology, 132
E. Verrier, Lijun Wang, C. Wadham, N. Albanese, C. Hahn, Jennifer Gamble, V. Chatterjee, Mathew Vadas, P. Xia (2004)
PPARγ Agonists Ameliorate Endothelial Cell Activation via Inhibition of Diacylglycerol–Protein Kinase C Signaling Pathway: Role of Diacylglycerol KinaseCirculation Research: Journal of the American Heart Association, 94
S. Vandevoorde, S. Vandevoorde, K. Jonsson, G. Labar, Emma Persson, Didier Lambert, Christopher Fowler (2007)
Lack of selectivity of URB602 for 2‐oleoylglycerol compared to anandamide hydrolysis in vitroBritish Journal of Pharmacology, 150
M. Bracey, M. Hanson, K. Masuda, R. Stevens, B. Cravatt (2002)
Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid SignalingScience, 298
G. Ahern (2003)
Activation of TRPV1 by the Satiety Factor Oleoylethanolamide*Journal of Biological Chemistry, 278
W. Edgemond, Cecilia Hillard, J. Falck, C. Kearn, William Campbell (1998)
Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation.Molecular pharmacology, 54 1
(2004)
Screening assays for cannabinoid-ligand-type modulators of GPR55. Patent Application
Judit Makara, M. Mor, D. Fegley, S. Szabó, S. Kathuria, G. Astarita, A. Duranti, A. Tontini, G. Tarzia, S. Rivara, T. Freund, D. Piomelli (2007)
Erratum: Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus (Nature Neuroscience (2005) 8, (1139-1141))Nature Neuroscience, 10
R. Bron, L. Klesse, K. Shah, L. Parada, J. Winter (2003)
Activation of Ras is necessary and sufficient for upregulation of vanilloid receptor type 1 in sensory neurons by neurotrophic factorsMolecular and Cellular Neuroscience, 22
A. Hampson, W. Hill, M. Zan-Phillips, A. Makriyannis, E. Leung, R. Eglen, L. Bornheim (1995)
Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor.Biochimica et biophysica acta, 1259 2
Jesse Verme, Jin Fu, G. Astarita, G. Rana, R. Russo, A. Calignano, D. Piomelli (2005)
The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of PalmitoylethanolamideMolecular Pharmacology, 67
T. Sugiura, S. Kondo, T. Kodaka, Takashi Tonegawa, S. Nakane, A. Yamashita, Y. Ishima, K. Waku (1996)
Enzymatic synthesis of oleamide (cis‐9,10‐octadecenoamide), an endogenous sleep‐inducing lipid, by rat brain microsomesIUBMB Life, 40
Di Marzo (2001b)
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cellsBiochem J, 358
M. López-Rodríguez, A. Viso, S. Ortega‐Gutiérrez, C. Fowler, G. Tiger, Eva Lago, J. Fernández-Ruiz, J. Ramos (2003)
Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.Journal of medicinal chemistry, 46 8
R. Russo, J. Loverme, G. Rana, G. D'Agostino, O. Sasso, A. Calignano, D. Piomelli (2007)
Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.European journal of pharmacology, 566 1-3
R. Condie, A. Herring, W. Koh, Michael Lee, N. Kaminski (1996)
Cannabinoid Inhibition of Adenylate Cyclase-mediated Signal Transduction and Interleukin 2 (IL-2) Expression in the Murine T-cell Line, EL4.IL-2*The Journal of Biological Chemistry, 271
T. Bisogno, D. Melck, L. Petrocellis, V. Marzo (1999)
Phosphatidic Acid as the Biosynthetic Precursor of the Endocannabinoid 2‐Arachidonoylglycerol in Intact Mouse Neuroblastoma Cells Stimulated with IonomycinJournal of Neurochemistry, 72
S. Kathuria, S. Gaetani, D. Fegley, F. Valiño, A. Duranti, A. Tontini, M. Mor, G. Tarzia, G. Rana, A. Calignano, A. Giustino, M. Tattoli, M. Palmery, V. Cuomo, D. Piomelli (2003)
Modulation of anxiety through blockade of anandamide hydrolysisNature Medicine, 9
J. Leggett, S. Aspley, S. Beckett, A. D'Antona, D. Kendall, D. Kendall (2004)
Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptorsBritish Journal of Pharmacology, 141
H. Hermann, L. Petrocellis, T. Bisogno, A. Moriello, B. Lutz, V. Marzo (2003)
Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated responseCellular and Molecular Life Sciences CMLS, 60
R. Nicholson, Jian Zheng, C. Ganellin, B. Verdon, G. Lees (2001)
Anesthetic-like Interaction of the Sleep-inducing Lipid Oleamide with Voltage-gated Sodium Channels in Mammalian BrainAnesthesiology, 94
Kirsten Kempe, F. Hsu, A. Bohrer, J. Turk (1996)
Isotope Dilution Mass Spectrometric Measurements Indicate That Arachidonylethanolamide, the Proposed Endogenous Ligand of the Cannabinoid Receptor, Accumulates in Rat Brain Tissue Post Mortem but Is Contained at Low Levels in or Is Absent from Fresh Tissue*The Journal of Biological Chemistry, 271
T. Akiyama, S. Sakai, G. Lambert, C. Nicol, K. Matsusue, Satish Pimprale, Ying-Hue Lee, M. Ricote, C. Glass, H. Brewer, F. Gonzalez (2002)
Conditional Disruption of the Peroxisome Proliferator-Activated Receptor γ Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol EffluxMolecular and Cellular Biology, 22
Hampson Hampson, Hill Hill, Zanphillips Zanphillips, Makriyannis Makriyannis, Leung Leung, Eglen Eglen (1995a)
Anandamide hydroxylation by brain lipoxygenase: metabolite structures and potencies at the cannabinoid receptorBiochim Biophys Acta—Lip Lip Met, 1259
K. Mackie (2006)
Cannabinoid receptors as therapeutic targets.Annual review of pharmacology and toxicology, 46
Saori Oka, A. Tsuchie, A. Tokumura, M. Muramatsu, Y. Suhara, H. Takayama, K. Waku, T. Sugiura (2003)
Ether‐linked analogue of 2‐arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian speciesJournal of Neurochemistry, 85
M. Duncan, P. Millns, D. Smart, J. Wright, D. Kendall, V. Ralevic (2004)
Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non‐CB1/CB2 Gi/o linked receptorBritish Journal of Pharmacology, 142
Y. Sun (2006)
Cannabinoids and PPARa signalling.
Identification functional characterization of brainstem cannabinoid CB2 receptors.
Dan Giang, B. Cravatt (1997)
Molecular characterization of human and mouse fatty acid amide hydrolases.Proceedings of the National Academy of Sciences of the United States of America, 94 6
L. Petrocellis, P. Marini, I. Matias, A. Moriello, K. Starowicz, L. Cristino, S. Nigam, V. Marzo (2007)
Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells.Experimental cell research, 313 14
Di Zhang, Anita Saraf, T. Kolasa, P. Bhatia, G. Zheng, Meena Patel, G. Lannoye, P. Richardson, A. Stewart, J. Rogers, J. Brioni, C. Surowy (2007)
Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targetsNeuropharmacology, 52
M. Glass, M. Dragunow (1995)
Induction of the Krox 24 transcription factor in striosomes by a cannabinoid agonist.Neuroreport, 6 2
K. Kozak, S. Rowlinson, L. Marnett (2000)
Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2*The Journal of Biological Chemistry, 275
C. Felder, A. Dickason-Chesterfield, S. Moore (2006)
Cannabinoids biology: the search for new therapeutic targets.Molecular interventions, 6 3
W. Ho, C. Hiley (2004)
Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric arteryJournal of Pharmacy and Pharmacology, 56
P. Schmid, D. Schwindenhammer, R. Krebsbach, H. Schmid (1998)
Alternative pathways of anandamide biosynthesis in rat testes.Chemistry and physics of lipids, 92 1
Mutsumi Sugita, Marcia Williams, J. Dulaney, Hugo Moser (1975)
Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase.Biochimica et biophysica acta, 398 1
D. Centonze, A. Finazzi-Agrò, G. Bernardi, M. Maccarrone (2007)
The endocannabinoid system in targeting inflammatory neurodegenerative diseases.Trends in pharmacological sciences, 28 4
C. Rockwell, N. Kaminski (2004)
A Cyclooxygenase Metabolite of Anandamide Causes Inhibition of Interleukin-2 Secretion in Murine SplenocytesJournal of Pharmacology and Experimental Therapeutics, 311
L. Petrocellis, P. Orlando, V. Marzo (1995)
Anandamide, an endogenous cannabinomimetic substance, modulates rat brain protein kinase C in vitro.Biochemistry and molecular biology international, 36 6
T. Bisogno, D. Melck, Bobrov MYu, N. Gretskaya, V. Bezuglov, L. Petrocellis, V. Marzo (2000)
N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.The Biochemical journal, 351 Pt 3
Barbara Bosier, Sébastien Tilleux, M. Najimi, D. Lambert, E. Hermans (2007)
Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell lineJournal of Neurochemistry, 102
M. Oz, A. Alptekin, Y. Tchugunova, M. Dinç (2005)
Effects of saturated long-chain N-acylethanolamines on voltage-dependent Ca2+ fluxes in rabbit T-tubule membranes.Archives of biochemistry and biophysics, 434 2
R. Ji, T. Samad, Shan-xue Jin, Raymond Schmoll, C. Woolf (2002)
p38 MAPK Activation by NGF in Primary Sensory Neurons after Inflammation Increases TRPV1 Levels and Maintains Heat HyperalgesiaNeuron, 36
R. Pertwee (2006)
Cannabinoid pharmacology: the first 66 yearsBritish Journal of Pharmacology, 147
Z. Oláh, L. Kárai, M. Iadarola (2002)
Protein Kinase Cα Is Required for Vanilloid Receptor 1 ActivationThe Journal of Biological Chemistry, 277
V. Marzo, T. Bisogno, L. Petrocellis (2001)
Anandamide: some like it hot.Trends in pharmacological sciences, 22 7
Z. Járai, J. Wagner, J. Wagner, K. Varga, K. Lake, D. Compton, B. Martin, A. Zimmer, T. Bonner, N. Buckley, É. Mezey, R. Razdan, A. Zimmer, G. Kunos (1999)
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.Proceedings of the National Academy of Sciences of the United States of America, 96 24
Fei Chen, Muchung Wang, J. O’Connor, Mai He, T. Tripathi, L. Harrison (2003)
Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF‐κβJournal of Cellular Biochemistry, 90
D. Gebremedhin, A. Lange, W. Campbell, C. Hillard, D. Harder (1999)
Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current.The American journal of physiology, 276 6
D. Garcia, S. Brown, B. Hille, K. Mackie (1998)
Protein Kinase C Disrupts Cannabinoid Actions by Phosphorylation of the CB1 Cannabinoid ReceptorThe Journal of Neuroscience, 18
M. Maccarrone, S. Cecconi, G. Rossi, N. Battista, Riccardo Pauselli, A. Finazzi-Agrò (2003)
Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells.Endocrinology, 144 1
Jason Clapper, A. Duranti, A. Tontini, M. Mor, G. Tarzia, D. Piomelli (2006)
The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues.Pharmacological research, 54 5
L. Petrocellis, K. Starowicz, A. Moriello, Marta Vivese, P. Orlando, V. Marzo (2007)
Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids.Experimental cell research, 313 9
C. Spivak, C. Lupica, M. Oz (2007)
The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors.Molecular pharmacology, 72 4
G. Milman, Y. Maor, S. Abu-Lafi, M. Horowitz, R. Gallily, S. Batkai, F. Mo, László Offertáler, P. Pacher, G. Kunos, R. Mechoulam (2006)
N-arachidonoyl l-serine, an endocannabinoid-like brain constituent with vasodilatory propertiesProceedings of the National Academy of Sciences of the United States of America, 103
V. Marzo, D. Melck, P. Orlando, T. Bisogno, Orna Zagoory, M. Bifulco, Zvi Vogel, L. Petrocellis (2001)
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.The Biochemical journal, 358 Pt 1
S. Turkanis, L. Partlow, R. Karler (1991)
Delta-9-tetrahydrocannabinol depresses inward sodium current in mouse neuroblastoma cellsNeuropharmacology, 30
M. McFarland, E. Barker (2005)
Lipid rafts: a nexus for endocannabinoid signaling?Life sciences, 77 14
K. Tsuboi, Christine Hilligsmann, S. Vandevoorde, D. Lambert, N. Ueda (2004)
N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.The Biochemical journal, 379 Pt 1
David Robbe, G. Alonso, Florence Duchamp, J. Bockaert, O. Manzoni (2001)
Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus AccumbensThe Journal of Neuroscience, 21
Sumner Burstein, R. Rossetti, Boris Yagen, Robert Zurier (2000)
Oxidative metabolism of anandamide.Prostaglandins & other lipid mediators, 61 1-2
X. Guan, B. Cravatt, G. Ehring, James Hall, D. Boger, R. Lerner, N. Gilula (1997)
The Sleep-inducing Lipid Oleamide Deconvolutes Gap Junction Communication and Calcium Wave Transmission in Glial CellsThe Journal of Cell Biology, 139
K. Tsuboi, Li-ying Zhao, Y. Okamoto, N. Araki, M. Ueno, H. Sakamoto, N. Ueda (2007)
Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies.Biochimica et biophysica acta, 1771 5
A. Liapi, J. Wood (2005)
Extensive co‐localization and heteromultimer formation of the vanilloid receptor‐like protein TRPV2 and the capsaicin receptor TRPV1 in the adult rat cerebral cortexEuropean Journal of Neuroscience, 22
Sugiura Sugiura, Kondo Kondo, Kishimoto Kishimoto, Miyashita Miyashita, Nakane Nakane, Kodaka Kodaka (2000)
Evidence that 2‐arachidonoylglycerol but not N ‐palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL‐60 cellsJ Biol Chem, 275
E. Carrier, C. Kearn, A. Barkmeier, Nicole Breese, Wenqi Yang, K. Nithipatikom, S. Pfister, W. Campbell, C. Hillard (2004)
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism.Molecular pharmacology, 65 4
Ueda Ueda, Yamamoto Yamamoto, Yamamoto Yamamoto, Tokunaga Tokunaga, Shirakawa Shirakawa, Shinkai Shinkai (1995)
Lipoxygenase‐catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonistBiochim Biophys Acta—Lip Lip Met, 1254
Mario Stelt, M. Trevisani, V. Vellani, L. Petrocellis, A. Moriello, B. Campi, P. McNaughton, P. Geppetti, V. Marzo (2005)
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channelsThe EMBO Journal, 24
J. Shoemaker, Michael Ruckle, P. Mayeux, P. Prather (2005)
Agonist-Directed Trafficking of Response by Endocannabinoids Acting at CB2 ReceptorsJournal of Pharmacology and Experimental Therapeutics, 315
Jie Liu, Lei Wang, J. Harvey‐White, D. Osei-Hyiaman, R. Razdan, Qian Gong, A. Chan, Zhifeng Zhou, Bill Huang, Hee-Yong Kim, G. Kunos (2006)
A biosynthetic pathway for anandamideProceedings of the National Academy of Sciences, 103
P. Carriba, O. Ortiz, Kshitij Patkar, Z. Justinova, Jessica Stroik, Andrea Themann, C. Müller, A. Woods, B. Hope, F. Ciruela, V. Casadó, E. Canela, C. Lluis, S. Goldberg, R. Moratalla, R. Franco, S. Ferré (2007)
Striatal Adenosine A2A and Cannabinoid CB1 Receptors Form Functional Heteromeric Complexes that Mediate the Motor Effects of CannabinoidsNeuropsychopharmacology, 32
Susan Huang, T. Bisogno, Timothy Petros, Sai Chang, Paul Zavitsanos, R. Zipkin, R. Sivakumar, A. Coop, Dean Maeda, L. Petrocellis, S. Burstein, V. Marzo, J. Walker (2001)
Identification of a New Class of Molecules, the Arachidonyl Amino Acids, and Characterization of One Member That Inhibits Pain*The Journal of Biological Chemistry, 276
T. Sugiura, S. Kishimoto, Saori Oka, Maiko Gokoh (2006)
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.Progress in lipid research, 45 5
P. Nieri, N. Romiti, B. Adinolfi, A. Chicca, Ilaria Massarelli, E. Chieli (2006)
Modulation of P‐glycoprotein activity by cannabinoid molecules in HK‐2 renal cellsBritish Journal of Pharmacology, 148
M. Tominaga, M. Wada, M. Masu (2001)
Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesiaProceedings of the National Academy of Sciences of the United States of America, 98
A. Porter, J. Sauer, M. Knierman, G. Becker, M. Berna, J. Bao, G. Nomikos, Petra Carter, F. Bymaster, Andrea Leese, C. Felder (2002)
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.The Journal of pharmacology and experimental therapeutics, 301 3
Isabelle Matias, June Chen, L. Petrocellis, T. Bisogno, Alessia Ligresti, F. Fezza, A. Krauss, L. Shi, C. Protzman, Chen Li, Yanbin Liang, A. Nieves, K. Kedzie, R. Burk, V. Marzo, D. Woodward (2004)
Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and MetabolismJournal of Pharmacology and Experimental Therapeutics, 309
L. Premkumar, G. Ahern (2000)
Induction of vanilloid receptor channel activity by protein kinase CNature, 408
Masashi Kohno, H. Hasegawa, A. Inoue, M. Muraoka, T. Miyazaki, Keizo Oka, M. Yasukawa (2006)
Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18.Biochemical and biophysical research communications, 347 3
E. Berdyshev, P. Schmid, R. Krebsbach, Cecilia Hillard, Chuanshu Huang, N. Chen, Zigang Dong, Harald Schmid (2001)
Cannabinoid-receptor-independent cell signalling by N-acylethanolamines.The Biochemical journal, 360 Pt 1
R. Nicholson, Chengyong Liao, Jian Zheng, Laurence David, L. Coyne, A. Errington, G. Singh, G. Lees (2003)
Sodium channel inhibition by anandamide and synthetic cannabimimetics in brainBrain Research, 978
Fang Fang, Hu Hu, Xu Xu, Snyder Snyder, Harmon Harmon, Yao Yao (2006)
14,15‐Dihydroxyeicosatrienoic acid activates peroxisome proliferator‐activated receptor‐αAm J Physiol—Heart Circ Physiol, 290
L. Petrocellis, T. Bisogno, John Davis, R. Pertwee, V. Marzo (2000)
Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activityFEBS Letters, 483
J. Prusakiewicz, Melissa Turman, A. Vila, Heather Ball, Ahmad Al-Mestarihi, V. Marzo, L. Marnett (2007)
Oxidative metabolism of lipoamino acids and vanilloids by lipoxygenases and cyclooxygenases.Archives of biochemistry and biophysics, 464 2
Kozak Kozak, Gupta Gupta, Moody Moody, Ji Ji, Boeglin Boeglin, DuBois DuBois (2002)
15‐Lipoxygenase metabolism of 2‐arachidonylglycerol: Generation of a PPARα agonistJ Biol Chem, 277
L. Bornheim, Kelly Kim, Baili Chen, M. Correia (1995)
Microsomal cytochrome P450-mediated liver and brain anandamide metabolism.Biochemical pharmacology, 50 5
E. Högestätt, B. Jönsson, Anna Ermund, D. Andersson, H. Björk, J. Alexander, B. Cravatt, A. Basbaum, P. Zygmunt (2005)
Conversion of Acetaminophen to the Bioactive N-Acylphenolamine AM404 via Fatty Acid Amide Hydrolase-dependent Arachidonic Acid Conjugation in the Nervous System*Journal of Biological Chemistry, 280
J. Sipe, N. Arbour, A. Gerber, E. Beutler (2005)
Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disordersJournal of Leukocyte Biology, 78
Susan Huang, T. Bisogno, M. Trevisani, A. Al-Hayani, L. Petrocellis, F. Fezza, M. Tognetto, Timothy Petros, Jocelyn Krey, Constance Chu, Jeffrey Miller, S. Davies, P. Geppetti, J. Walker, V. Marzo (2002)
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptorsProceedings of the National Academy of Sciences of the United States of America, 99
K. Jonsson, S. Holt, C. Fowler (2006)
The endocannabinoid system: current pharmacological research and therapeutic possibilities.Basic & clinical pharmacology & toxicology, 98 2
Toth Toth, Boczan Boczan, Kedei Kedei, Lizanecz Lizanecz, Bagi Bagi, Papp Papp (2005)
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brainMol Brain Res, 135
T. Sugiura, T. Kodaka, S. Kondo, Takashi Tonegawa, S. Nakane, S. Kishimoto, A. Yamashita, K. Waku (1996)
2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells.Biochemical and biophysical research communications, 229 1
H. Kim, Tae Kim, Y. Shin, Chung-Soo Lee, Mijung Park, Jin-Ho Song (2005)
Anandamide suppression of Na+ currents in rat dorsal root ganglion neuronsBrain Research, 1062
Sugiura Sugiura, Kondo Kondo, Kodaka Kodaka, Tonegawa Tonegawa, Nakane Nakane, Yamashita Yamashita (1996b)
Enzymatic synthesis of oleamide ( cis ‐9,10‐octadenoamide), an endogenous sleep‐inducing lipid, by rat brain microsomesBiochem Molec Biol Int, 40
B. Alger (2002)
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoidsProgress in Neurobiology, 68
Rudolph Marsch, E. Foeller, G. Rammes, M. Bunck, M. Kössl, F. Holsboer, W. Zieglgänsberger, R. Landgraf, B. Lutz, C. Wotjak (2007)
Reduced Anxiety, Conditioned Fear, and Hippocampal Long-Term Potentiation in Transient Receptor Potential Vanilloid Type 1 Receptor-Deficient MiceThe Journal of Neuroscience, 27
Chengyong Liao, Jian Zheng, Laurence David, R. Nicholson (2004)
Inhibition of voltage-sensitive sodium channels by the cannabinoid 1 receptor antagonist AM 251 in mammalian brain.Basic & clinical pharmacology & toxicology, 94 2
M. Mor, S. Rivara, A. Lodola, P. Plazzi, G. Tarzia, A. Duranti, A. Tontini, G. Piersanti, S. Kathuria, D. Piomelli (2004)
Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.Journal of medicinal chemistry, 47 21
A. Fisyunov, V. Tsintsadze, Rogier Min, N. Burnashev, N. Lozovaya (2006)
Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons.Journal of neurophysiology, 96 3
P. Zygmunt, H. Chuang, P. Movahed, D. Julius, E. Högestätt (2000)
The anandamide transport inhibitor AM404 activates vanilloid receptors.European journal of pharmacology, 396 1
T. Bisogno, M. Cascio, B. Saha, A. Mahadevan, P. Urbani, Alberto Minassi, G. Appendino, C. Saturnino, B. Martin, R. Razdan, V. Marzo (2006)
Development of the first potent and specific inhibitors of endocannabinoid biosynthesis.Biochimica et biophysica acta, 1761 2
Y. Okamoto, J. Morishita, K. Tsuboi, T. Tonai, N. Ueda (2004)
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners*Journal of Biological Chemistry, 279
C. Felder, K. Joyce, E. Briley, J. Mansouri, K. Mackie, O. Blond, Y. Lai, A. Ma, R. Mitchell (1995)
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.Molecular pharmacology, 48 3
Olah Olah, Karai Karai, Iadarola Iadarola (2002)
Protein kinase Cα is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathwaysJ Biol Chem, 277
Jooyoung Jung, J. Shin, Soon-youl Lee, S. Hwang, J. Koo, Hawon Cho, U. Oh (2004)
Phosphorylation of Vanilloid Receptor 1 by Ca2+/Calmodulin-dependent Kinase II Regulates Its Vanilloid Binding*Journal of Biological Chemistry, 279
M. Bouaboula, B. Bourrié, M. Rinaldi-Carmona, D. Shire, G. Fur, P. Casellas (1995)
Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells (*)The Journal of Biological Chemistry, 270
C. Shi, A. Szcześniak, L. Mao, C. Jollimore, M. Coca‐Prados, O. Hung, M. Kelly (2003)
A3 adenosine and CB1 receptors activate a PKC‐sensitive Cl− current in human nonpigmented ciliary epithelial cells via a Gβγ‐coupled MAPK signaling pathwayBritish Journal of Pharmacology, 139
(2007)
An investigation of lipoxygenase inhibitors as potential inhibitors of fatty acid amide hydrolase
Vasumati Pestonjamasp, Sumner Burstein (1998)
Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system.Biochimica et biophysica acta, 1394 2-3
Endocannabinoid action and metabolism
S. Saario, V. Palomäki, M. Lehtonen, T. Nevalainen, T. Järvinen, J. Laitinen (2006)
URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain.Chemistry & biology, 13 8
M. Bouaboula, S. Hilairet, J. Marchand, L. Fajas, G. Fur, P. Casellas (2005)
Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.European journal of pharmacology, 517 3
A. Hoffman, C. Lupica (2000)
Mechanisms of Cannabinoid Inhibition of GABAASynaptic Transmission in the HippocampusThe Journal of Neuroscience, 20
Xenopus Oz, Li Zhang, A. Ravindran, M. Morales, C. Lupica, Neurobiology Branch, M. MuratOz (2004)
1 DIFFERENTIAL EFFECTS OF ENDOGENOUS AND SYNTHETIC CANNABINOIDS ON α 7 -NICOTINIC ACETYLCHOLINE RECEPTOR-MEDIATED RESPONSES IN XENOPUS OOCYTES.
François Maingret, Amanda Patel, M. Lazdunski, E. Honoré (2001)
The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK‐1The EMBO Journal, 20
L. Facci, R. Toso, S. Romanello, A. Buriani, S. Skaper, A. Leon (1995)
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.Proceedings of the National Academy of Sciences of the United States of America, 92
L. Venance, D. Piomelli, J. Glowinski, Christian Glaume (1995)
Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytesNature, 376
(1994)
Synergistic interaction between glutamate analogues and histamine receptor-stimulated phosphoinositide turnover
C. Fowler, G. Tiger, A. Ligresti, M. López-Rodríguez, V. Marzo (2004)
Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.European journal of pharmacology, 492 1
M. Steffens, T. Feuerstein (2004)
Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex—involvement of Na+/K+-ATPaseNeurochemistry International, 44
M. Oz, A. Ravindran, O. Dı́az-Ruiz, Li Zhang, M. Morales (2003)
The Endogenous Cannabinoid Anandamide Inhibits α7 Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus OocytesJournal of Pharmacology and Experimental Therapeutics, 306
A. Jarrahian, S. Manna, W. Edgemond, W. Campbell, C. Hillard (2000)
Structure—Activity Relationships Among N‐Arachidonylethanolamine (Anandamide) Head Group Analogues for the Anandamide TransporterJournal of Neurochemistry, 74
W. Jin, Sean Brown, J. Roche, C. Hsieh, J. Celver, A. Kovoor, C. Chavkin, K. Mackie (1999)
Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and InternalizationThe Journal of Neuroscience, 19
S. Ben-Shabat, E. Fride, T. Sheskin, T. Tamiri, Man-Hee Rhee, Z. Vogel, T. Bisogno, L. Petrocellis, V. Marzo, R. Mechoulam (1998)
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.European journal of pharmacology, 353 1
G. Bhave, Weiguo Zhu, Haibin Wang, D. Brasier, G. Oxford, R. Gereau (2002)
cAMP-Dependent Protein Kinase Regulates Desensitization of the Capsaicin Receptor (VR1) by Direct PhosphorylationNeuron, 35
P. Movahed, B. Jönsson, B. Birnir, Johan Wingstrand, T. Jørgensen, Anna Ermund, O. Sterner, P. Zygmunt, E. Högestätt (2005)
Endogenous Unsaturated C18 N-Acylethanolamines Are Vanilloid Receptor (TRPV1) Agonists*Journal of Biological Chemistry, 280
C. Nirodi, B. Crews, K. Kozak, J. Morrow, L. Marnett (2004)
The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cellsProceedings of the National Academy of Sciences of the United States of America, 101
G. Ortar, M. Cascio, A. Moriello, M. Camalli, E. Morera, M. Nalli, V. Marzo (2008)
Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation.European journal of medicinal chemistry, 43 1
T. Harkany, M. Guzmán, I. Galve-Roperh, P. Berghuis, L. Devi, K. Mackie (2007)
The emerging functions of endocannabinoid signaling during CNS development.Trends in pharmacological sciences, 28 2
Yan Sun, Stephen Alexander, M. Garle, C. Gibson, K. Hewitt, S. Murphy, D. Kendall, A. Bennett (2007)
Cannabinoid activation of PPARα; a novel neuroprotective mechanismBritish Journal of Pharmacology, 152
D. Deutsch, S. Glaser, J. Howell, Jeffrey Kunz, R. Puffenbarger, C. Hillard, N. Abumrad (2001)
The Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide Hydrolase*The Journal of Biological Chemistry, 276
Amy Wiles, Rhonda‐Jo Pearlman, M. Rosvall, K. Aubrey, R. Vandenberg (2006)
N‐Arachidonyl‐glycine inhibits the glycine transporter, GLYT2aJournal of Neurochemistry, 99
K. Mishima, K. Hayakawa, K. Abe, T. Ikeda, N. Egashira, K. Iwasaki, M. Fujiwara (2005)
Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine1A Receptor–Dependent MechanismStroke, 36
Driscoll Driscoll, Chaturvedi Chaturvedi, Mueller Mueller (2007)
Oleamide synthesizing activity from rat kidney: identification as cytochrome cJ Biol Chem, 282
M. Bouaboula, D. Dussossoy, Pierre Casellas (1999)
Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses.The Journal of biological chemistry, 274 29
(2018)
Arachidonic Acid
Y. Kurahashi, Natsuo Ueda, Hiroshi Suzuki, Mitsujiro Suzuki, Shozo Yamamoto (1997)
Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase.Biochemical and biophysical research communications, 237 3
Berdyshev (2001)
Cannabinoid-receptor-independent cell signalling by N-acylethanolaminesBiochem J, 360
Carrie Rokos, B. Ledwith (1997)
Peroxisome Proliferators Activate Extracellular Signal-regulated Kinases in Immortalized Mouse Liver Cells*The Journal of Biological Chemistry, 272
P. Zygmunt, J. Petersson, D. Andersson, H. Chuang, M. Sørgård, V. Marzo, D. Julius, E. Högestätt (1999)
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamideNature, 400
J. Fernández-Ruiz, J. Romero, G. Velasco, R. Tolón, J. Ramos, M. Guzmán (2007)
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?Trends in pharmacological sciences, 28 1
V. Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J. Schwartz, D. Piomelli (1994)
Formation and inactivation of endogenous cannabinoid anandamide in central neuronsNature, 372
Susan Craib, Heather Ellington, R. Pertwee, R. Ross (2001)
A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea‐pig bronchusBritish Journal of Pharmacology, 134
Natasha Snider, A. Kornilov, U. Kent, P. Hollenberg (2007)
Anandamide Metabolism by Human Liver and Kidney Microsomal Cytochrome P450 Enzymes to Form Hydroxyeicosatetraenoic and Epoxyeicosatrienoic Acid EthanolamidesJournal of Pharmacology and Experimental Therapeutics, 321
M. Zoete, A. Dalen, F. Rantwijk, R. Sheldon (1996)
Lipase-catalysed ammoniolysis of lipids. A facile synthesis of fatty acid amidesJournal of Molecular Catalysis B-enzymatic, 1
E. Downer, M. Fogarty, V. Campbell (2003)
Tetrahydrocannabinol‐induced neurotoxicity depends on CB1 receptor‐mediated c‐Jun N‐terminal kinase activation in cultured cortical neuronsBritish Journal of Pharmacology, 140
B. Wei, T. Mikkelsen, Michele McKinney, E. Lander, B. Cravatt (2006)
A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals*Journal of Biological Chemistry, 281
Jin Fu, S. Gaetani, F. Oveisi, J. Verme, A. Serrano, F. Fonseca, A. Rosengarth, H. Luecke, B. Giacomo, G. Tarzia, D. Piomelli (2003)
Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-αNature, 425
J. Prusakiewicz, P. Kingsley, K. Kozak, L. Marnett (2002)
Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2.Biochemical and biophysical research communications, 296 3
P. Derkinderen, M. Toutant, F. Burgaya, M. Bert, J. Siciliano, V. Franciscis, M. Gelman, J. Girault (1996)
Regulation of a Neuronal Form of Focal Adhesion Kinase by AnandamideScience, 273
Yong-xin Sun, K. Tsuboi, Li-ying Zhao, Y. Okamoto, D. Lambert, N. Ueda (2005)
Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.Biochimica et biophysica acta, 1736 3
Chiung‐Chun Huang, Shiow-Win Lo, K. Hsu (2001)
Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neuronsThe Journal of Physiology, 532
V. Marzo, T. Bisogno, L. Petrocellis (2007)
Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology.Chemistry & biology, 14 7
L. Hanuš, S. Abu-Lafi, E. Fride, A. Breuer, Z. Vogel, D. Shalev, I. Kustanovich, R. Mechoulam (2001)
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptorProceedings of the National Academy of Sciences of the United States of America, 98
D. Rueda, I. Galve-Roperh, A. Haro, M. Guzmán (2000)
The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase.Molecular pharmacology, 58 4
Kogan Nm, R. Mechoulam (2006)
The chemistry of endocannabinoids.Journal of endocrinological investigation, 29 3 Suppl
J. Jerman, J. Gray, S. Brough, L. Ooi, D. Owen, J. Davis, D. Smart (2002)
Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.British journal of anaesthesia, 89 6
D. Smart, K. Jonsson, S. Vandevoorde, D. Lambert, C. Fowler (2002)
‘Entourage’ effects of N‐acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide‐induced vanilloid receptor activation and upon anandamide metabolismBritish Journal of Pharmacology, 136
N. Ueda, Kei Yamamoto, Shozo Yamamoto, T. Tokunaga, E. Shirakawa, H. Shinkai, M. Ogawa, Takuji Sato, I. Kudo, Keizō Inoue, H. Takizawa, T. Nagano, M. Hirobe, N. Matsuki, H. Saito (1995)
Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist.Biochimica et biophysica acta, 1254 2
S. Deadwyler, R. Hampson, J. Mu, A. Whyte, S. Childers (1995)
Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process.The Journal of pharmacology and experimental therapeutics, 273 2
T. Sugiura, S. Kondo, S. Kishimoto, T. Miyashita, S. Nakane, T. Kodaka, Y. Suhara, H. Takayama, K. Waku (2000)
Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 ReceptorThe Journal of Biological Chemistry, 275
B. Verdon, Jian Zheng, R. Nicholson, C Ganelli, G. Lees (2000)
Stereoselective modulatory actions of oleamide on GABAA receptors and voltage‐gated Na+ channels in vitro: a putative endogenous ligand for depressant drug sites in CNSBritish Journal of Pharmacology, 129
C. Felder, E. Briley, J. Axelrod, J. Simpson, K. Mackie, W. Devane (1993)
Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.Proceedings of the National Academy of Sciences of the United States of America, 90 16
Hao‐Jie Zhu, Jun-sheng Wang, John Markowitz, J. Donovan, Bryan Gibson, H. Gefroh, C. Devane (2006)
Characterization of P-glycoprotein Inhibition by Major Cannabinoids from MarijuanaJournal of Pharmacology and Experimental Therapeutics, 317
T. Bisogno, F. Howell, Gareth Williams, Alberto Minassi, M. Cascio, A. Ligresti, I. Matias, Aniello Schiano-Moriello, Praveen Paul, E. Williams, Uma Gangadharan, C. Hobbs, V. Marzo, P. Doherty (2003)
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brainThe Journal of Cell Biology, 163
Anatol Kreitzer, W. Regehr (2001)
Retrograde Inhibition of Presynaptic Calcium Influx by Endogenous Cannabinoids at Excitatory Synapses onto Purkinje CellsNeuron, 29
T. Sheskin, L. Hanuš, J. Slager, Zvi Vogel, Raphael Mechoulam (1997)
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor.Journal of medicinal chemistry, 40 5
Mario Stelt, V. Marzo (2005)
Anandamide as an intracellular messenger regulating ion channel activity.Prostaglandins & other lipid mediators, 77 1-4
S. Kim, Da-Yong Lee, E. Chung, U. Oh, Seung-Up Kim, B. Jin (2005)
Transient Receptor Potential Vanilloid Subtype 1 Mediates Cell Death of Mesencephalic Dopaminergic Neurons In Vivo and In VitroThe Journal of Neuroscience, 25
Jens Skou, M. Esmann (1992)
The Na,K-ATPaseJournal of Bioenergetics and Biomembranes, 24
P. Hoi, C. Hiley (2006)
Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptorBritish Journal of Pharmacology, 147
Joseph Cheer, A. Cadogan, C. Marsden, Kevin Fone, Dave Kendall (1999)
Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptorsNeuropharmacology, 38
G. Chinetti, S. Lestavel, V. Bocher, A. Remaley, B. Neve, I. Torra, E. Teissier, A. Minnich, M. Jaye, N. Duverger, H. Brewer, J. Fruchart, V. Clavey, B. Staels (2001)
PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathwayNature Medicine, 7
C. Kearn, Katherine Blake-Palmer, E. Daniel, K. Mackie, M. Glass (2005)
Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk?Molecular Pharmacology, 67
G. Lazennec, G. Lazennec, L. Canaple, D. Saugy, W. Wahli (2000)
Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.Molecular endocrinology, 14 12
P. Schweitzer (2000)
Cannabinoids Decrease the K+ M-Current in Hippocampal CA1 NeuronsThe Journal of Neuroscience, 20
R. Mechoulam, S. Ben-Shabat, L. Hanuš, M. Ligumsky, N. Kaminski, A. Schatz, A. Gopher, S. Almog, B. Martin, D. Compton, R. Pertwee, G. Griffin, M. Bayewitch, J. Barg, Z. Vogel (1995)
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.Biochemical pharmacology, 50 1
P. Derkinderen, E. Valjent, M. Toutant, J. Corvol, H. Enslen, C. Ledent, J. Trzăskos, J. Caboche, J. Girault (2003)
Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in HippocampusThe Journal of Neuroscience, 23
E. Thomas, Monica Carson, Neal Mj, J. Sutcliffe (1997)
Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide.Proceedings of the National Academy of Sciences of the United States of America, 94 25
W. Devane, J. Axelrod (1994)
Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes.Proceedings of the National Academy of Sciences of the United States of America, 91 14
S. Maione, T. Bisogno, V. Novellis, E. Palazzo, L. Cristino, M. Valenti, S. Petrosino, V. Guglielmotti, F. Rossi, V. Marzo (2006)
Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 ReceptorsJournal of Pharmacology and Experimental Therapeutics, 316
Rhonda‐Jo Pearlman, K. Aubrey, R. Vandenberg (2003)
Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1aJournal of Neurochemistry, 84
Sonyuan Lin, A. Khanolkar, P. Fan, A. Goutopoulos, C. Qin, Demetris Papahadjis, A. Makriyannis (1998)
Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.Journal of medicinal chemistry, 41 27
James Ellis, J. Pediani, M. Canals, S. Milasta, G. Milligan (2006)
Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function*Journal of Biological Chemistry, 281
M. Holland, J. Panetta, J. Hoskins, M. Bebawy, B. Roufogalis, J. Allen, J. Arnold (2006)
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.Biochemical pharmacology, 71 8
A. Saghatelian, Michele McKinney, M. Bandell, A. Patapoutian, B. Cravatt (2006)
A FAAH-regulated class of N-acyl taurines that activates TRP ion channels.Biochemistry, 45 30
P. Fan (1995)
Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons.Journal of neurophysiology, 73 2
T. Sugiura, T. Kodaka, S. Kondo, S. Nakane, Hironori Kondo, K. Waku, Y. Ishima, Kazuhito Watanabe, I. Yamamoto (1997)
Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells.Journal of biochemistry, 122 4
D. Cota, M. Tschöp, T. Horvath, A. Levine (2006)
Cannabinoids, opioids and eating behavior: The molecular face of hedonism?Brain Research Reviews, 51
D. Slipetz, Gary O'Neill, L. Favreau, Claude Dufresne, Michel Gallant, Yves Gareau, Daniel Guay, M. Labelle, K. Metters (1995)
Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.Molecular pharmacology, 48 2
C. Rios, I. Gomes, L. Devi (2006)
μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesisBritish Journal of Pharmacology, 148
James O'Byrne, M. Hunt, D. Rai, M. Saeki, S. Alexson (2003)
The Human Bile Acid-CoA:Amino Acid N-Acyltransferase Functions in the Conjugation of Fatty Acids to Glycine*Journal of Biological Chemistry, 278
J. Derocq, O. Jbilo, M. Bouaboula, M. Ségui, C. Clère, P. Casellas (2000)
Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60The Journal of Biological Chemistry, 275
Jane Sullivan (1999)
Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons.Journal of neurophysiology, 82 3
J. Chemin, A. Monteil, E. Perez-Reyes, J. Nargeot, P. Lory (2001)
Direct inhibition of T‐type calcium channels by the endogenous cannabinoid anandamideThe EMBO Journal, 20
L. Coyne, G. Lees, R. Nicholson, Jian Zheng, Katherine Neufield (2002)
The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitroBritish Journal of Pharmacology, 135
S. Mukhopadhyay, A. Howlett (2005)
Chemically Distinct Ligands Promote Differential CB1 Cannabinoid Receptor-Gi Protein InteractionsMolecular Pharmacology, 67
W. Driscoll, S. Chaturvedi, G. Mueller (2007)
Oleamide Synthesizing Activity from Rat KidneyJournal of Biological Chemistry, 282
Kaczocha Kaczocha, Hermann Hermann, Glaser Glaser, Bojesen Bojesen, Deutsch Deutsch (2006)
Anandamide uptake is consistent with rate‐limited diffusion and is regulated by the degree of its hydrolysis by FAAHJ Biol Chem, 281
Peng Li, Miao Sun, B. Ho, J. Ding (2006)
The specificity of Sushi peptides for endotoxin and anionic phospholipids: potential application of POPG as an adjuvant for anti-LPS strategies.Biochemical Society transactions, 34 Pt 2
M. Bouaboula, D. Dussossoy, P. Casellas (1999)
Regulation of Peripheral Cannabinoid Receptor CB2Phosphorylation by the Inverse Agonist SR 144528The Journal of Biological Chemistry, 274
D. Demuth, A. Molleman (2006)
Cannabinoid signalling.Life sciences, 78 6
V. Marzo, L. Petrocellis (2006)
Plant, synthetic, and endogenous cannabinoids in medicine.Annual review of medicine, 57
V. Showalter, D. Compton, Billy Martin, M. Abood (1996)
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.The Journal of pharmacology and experimental therapeutics, 278 3
S. Vandevoorde, K. Jonsson, C. Fowler, D. Lambert (2003)
Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.Journal of medicinal chemistry, 46 8
Liu Liu, Batkai Batkai, Pacher Pacher, Harvey‐White Harvey‐White, Wagner Wagner, Cravatt Cravatt (2003)
LPS induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3‐kinase/NF‐κB independently of platelet activating factorJ Biol Chem, 278
T. Sugiura, T. Kodaka, S. Nakane, T. Miyashita, S. Kondo, Y. Suhara, H. Takayama, K. Waku, C. Seki, N. Baba, Y. Ishima (1999)
Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol ReceptorThe Journal of Biological Chemistry, 274
H. Chuang, E. Prescott, H. Kong, S. Shields, S. Jordt, A. Basbaum, M. Chao, D. Julius (2001)
Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibitionNature, 411
Jie Liu, S. Batkai, P. Pacher, J. Harvey‐White, J. Wagner, B. Cravatt, B. Gao, G. Kunos (2003)
Lipopolysaccharide Induces Anandamide Synthesis in Macrophages via CD14/MAPK/Phosphoinositide 3-Kinase/NF-κB Independently of Platelet-activating Factor*Journal of Biological Chemistry, 278
P. Derkinderen, C. Ledent, M. Parmentier, J. Girault (2001)
Cannabinoids activate p38 mitogen‐activated protein kinases through CB1 receptors in hippocampusJournal of Neurochemistry, 77
D. Woodward, A. Krauss, Jenny Wang, C. Protzman, A. Nieves, Yanbin Liang, Yariv Donde, R. Burk, K. Landsverk, C. Struble (2007)
Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin‐ethanolamides) in the feline irisBritish Journal of Pharmacology, 150
V. Gasperi, F. Fezza, P. Spagnuolo, N. Pasquariello, M. Maccarrone (2005)
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells.Neurotoxicology, 26 5
X. Fang, Shanming Hu, Bingkun Xu, G. Snyder, S. Harmon, Jianrong Yao, Yi Liu, Bhavani Sangras, J. Falck, N. Weintraub, A. Spector (2006)
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.American journal of physiology. Heart and circulatory physiology, 290 1
(2007)
Activation of PPARg in the presence of the selective FAAH inhibitor URB597
C. Juge-Aubry, E. Hammar, C. Siegrist-Kaiser, A. Pernin, Akira Takeshita, W. Chin, A. Burger, C. Meier (1999)
Regulation of the Transcriptional Activity of the Peroxisome Proliferator-activated Receptor α by Phosphorylation of a Ligand-independent trans-Activating Domain*The Journal of Biological Chemistry, 274
L. Petrocellis, S. Harrison, T. Bisogno, M. Tognetto, I. Brandi, Graham Smith, C. Creminon, John Davis, P. Geppetti, V. Marzo (2001)
The vanilloid receptor (VR1)‐mediated effects of anandamide are potently enhanced by the cAMP‐dependent protein kinaseJournal of Neurochemistry, 77
N. Jeske, A. Patwardhan, N. Gamper, Theodore Price, A. Akopian, K. Hargreaves (2006)
Cannabinoid WIN 55,212-2 Regulates TRPV1 Phosphorylation in Sensory Neurons*Journal of Biological Chemistry, 281
M. Kaczocha, A. Hermann, S. Glaser, I. Bojesen, D. Deutsch (2006)
Anandamide Uptake Is Consistent with Rate-limited Diffusion and Is Regulated by the Degree of Its Hydrolysis by Fatty Acid Amide Hydrolase*Journal of Biological Chemistry, 281
A. Mendiguren, J. Pineda (2004)
Cannabinoids enhance N-methyl-d-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slicesNeuroscience Letters, 363
K. Kozak, Rajnish Gupta, J. Moody, C. Ji, W. Boeglin, R. Dubois, A. Brash, L. Marnett (2002)
15-Lipoxygenase Metabolism of 2-ArachidonylglycerolThe Journal of Biological Chemistry, 277
Constance Chu, Susan Huang, L. Petrocellis, T. Bisogno, Scott Ewing, Jeffrey Miller, Robert Zipkin, Nives Daddario, G. Appendino, V. Marzo, J. Walker (2003)
N-Oleoyldopamine, a Novel Endogenous Capsaicin-like Lipid That Produces Hyperalgesia*The Journal of Biological Chemistry, 278
A. Hohmann, R. Suplita, Nathan Bolton, M. Neely, D. Fegley, R. Mangieri, Jocelyn Krey, J. Walker, P. Holmes, J. Crystal, A. Duranti, A. Tontini, M. Mor, G. Tarzia, D. Piomelli (2005)
An endocannabinoid mechanism for stress-induced analgesiaNature, 435
Judit Makara, M. Mor, D. Fegley, S. Szabó, S. Kathuria, G. Astarita, A. Duranti, A. Tontini, G. Tarzia, S. Rivara, T. Freund, D. Piomelli (2005)
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampusNature Neuroscience, 8
K. Kozak, L. Marnett (2002)
Oxidative metabolism of endocannabinoids.Prostaglandins, leukotrienes, and essential fatty acids, 66 2-3
L. Walter, A. Franklin, Anke Witting, C. Wade, Yiheng Xie, G. Kunos, K. Mackie, N. Stella (2003)
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell MigrationThe Journal of Neuroscience, 23
N. Ueda, K. Yamanaka, Shozo Yamamoto (2001)
Purification and Characterization of an Acid Amidase Selective for N-Palmitoylethanolamine, a Putative Endogenous Anti-inflammatory Substance*The Journal of Biological Chemistry, 276
M. Maccarrone, S. Salvati, M. Bari, Finazzi-Agró (2000)
Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade.Biochemical and biophysical research communications, 278 3
W‐Sv Ho, M. Randall (2007)
Endothelium‐dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2‐arachidonoylglycerolBritish Journal of Pharmacology, 150
Barbara Faubert, N. Kaminski (2000)
AP‐1 activity is negatively regulated by cannabinol through inhibition of its protein components, c‐fos and c‐junJournal of Leukocyte Biology, 67
F. Fezza, T. Bisogno, Alberto Minassi, G. Appendino, R. Mechoulam, V. Marzo (2002)
Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissuesFEBS Letters, 513
M. Bouaboula, Nathalie Desnoyer, P. Carayon, T. Combes, P. Casellas (1999)
Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation.Molecular pharmacology, 55 3
In this review, we present our understanding of the action and metabolism of endocannabinoids and related endogenous molecules. It is clear that the interactions between the multiple endocannabinoid‐like molecules (ECLs) are highly complex, both at the level of signal transduction and metabolism. Thus, ECLs are a group of ligands active at 7‐transmembrane and nuclear receptors, as well as transmitter‐gated and ion channels. ECLs and their metabolites can converge on common endpoints (either metabolic or signalling) through contradictory or reinforcing pathways. We highlight the complexity of the endocannabinoid system, based on the promiscuous nature of ECLs and their metabolites, as well as the synthetic modulators of the endocannabinoid system. British Journal of Pharmacology (2007) 152, 602–623; doi:10.1038/sj.bjp.0707456; published online 17 September 2007
British Journal of Pharmacology – Wiley
Published: Nov 1, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.